COMMUNIQUÉS West-GlobeNewswire

Information concerning the total number of voting rights and shares

12/02/2019 - 18:01

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l' [...]

Informations relatives au nombre total de droits de vote et d'actions

12/02/2019 - 18:01

Informations relatives au nombre total de droits de vote et d'actions prévues par l'article L. 233-8 II du Code de commerce et l'article 223-16 du Règlement général de l'Autorité des Marchés Financiers Sanofi Société [...]

Generex Announces Appointment of Marshal Schictman, Esq. as Executive Vice President General Counsel and Corporate SEC Attorney

12/02/2019 - 15:40

- Veteran Securities Attorney Joins Management to Guide M&A Initiatives, SEC Regulatory Affairs, and Generex Up-listing MIRAMAR, FL, Feb. 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Generex Biotechnology [...]

Update: Coloplast continues to expand its SenSura® Mio ostomy range with the new, innovative, first-of-its-kind SenSura® Mio Convex Flip ostomy product.

12/02/2019 - 15:31

Designed specifically for the outward body shapes – and the first of its kind in the ostomy market – the new SenSura® Mio Convex Flip is now available in the United States. All bodies are different, and it is a [...]

Imprivata Introduces Innovative, Proximity-Based Security Solution to Protect PHI on Shared Workstations

12/02/2019 - 15:25

Imprivata Proximity Aware Leverages the Power of Bluetooth Low Energy to Secure Workstations without Disrupting Clinical Workflow ORLANDO, Fla., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Imprivata® , the healthcare IT security [...]

Merit Medical Systems to Announce Fourth Quarter and Year End Results and 2019 Guidance on February 26, 2019

12/02/2019 - 15:25

SOUTH JORDAN, Utah, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and [...]

Nemaura Reports Third Quarter 2018 Financial Results

12/02/2019 - 15:15

Loughborough, England – Nemaura Medical, Inc. (NASDAQ: NMRD) nemauramedical.com , a medical technology company focused on the development of SugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose [...]

Anchiano Therapeutics Announces Pricing of $30.5 Million Initial Public Offering

12/02/2019 - 15:15

CAMBRIDGE, Mass., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq and TASE: ANCN) (“Anchiano”) today announced that it has priced its initial public offering of 2,652,174 of its American Depositary [...]

Ventura Cannabis to Acquire Cannabis Dispensaries in Cathedral City, California, and Portland, Oregon With Combined Annual Revenues of $2,500,000

12/02/2019 - 15:00

Secures Former Morgan Stanley, Merrill Lynch Executive as Senior Advisor NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ALL FIGURES IN CANADIAN DOLLARS UNLESS [...]

AXIM® Biotechnologies Announces Significant Initial Purchase Order for Nutraceutical Product With Leading Direct Selling Company

12/02/2019 - 15:00

NEW YORK, Feb. 12, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (“AXIM ® Biotech” or “AXIM”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced that the company has received [...]

Researchers at Queen’s University Belfast have Developed a Vaginal Ring Capable of Providing Sustained Delivery of OB-002 (5P12-RANTES) for HIV Prevention

12/02/2019 - 15:00

OTTAWA, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced that researchers at the School of Pharmacy, Queen’s University Belfast, have published [...]

Fortress Biotech Completes Final Stage Closing of the Sale of its Remaining Shares of National Holdings Corporation

12/02/2019 - 15:00

NEW YORK, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential clinical-stage [...]

Veritas Pharma Enters into agreement to acquire Commercial Hemp and Cannabis Processing Facility

12/02/2019 - 15:00

VANCOUVER, British Columbia, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it has entered into an agreement [...]

SELLAS Life Sciences Provides Galinpepimut-S and Nelipepimut-S Program Update

12/02/2019 - 14:45

Dr. Richard Maziarz and Dr. Roisin O'Cearbhaill Named Co-Principal Investigators for Galinpepimut-S (GPS) – Pembrolizumab Phase 1/2 Basket Trial Immune Response Data from the Phase 2b Nelipepimut-S (NPS) plus [...]

Teladoc Health to Announce Fourth Quarter and Full-Year 2018 Financial Results

12/02/2019 - 14:35

PURCHASE, NY, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in virtual care, announced today that it will release fourth quarter and full-year 2018 results on Wednesday, [...]

Ritter Pharmaceuticals to Host Expert Call with Dr. William Chey on February 20, 2019

12/02/2019 - 14:30

Leading Gastrointestinal Disease Expert to Address Unmet Medical Need in Lactose Intolerance and the Potential of Phase 3 Drug Candidate RP-G28 LOS ANGELES, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc [...]

Vericel to Report Fourth-Quarter 2018 Financial Results on February 26, 2019

12/02/2019 - 14:30

CAMBRIDGE, Mass., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the following webcast and [...]

Genocea Announces Private Placement Financing of Up to $39 Million

12/02/2019 - 14:30

CAMBRIDGE, Mass., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced that it has entered into a [...]

Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2018 Financial Results and Corporate Update

12/02/2019 - 14:30

NOVATO, Calif., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases [...]